Skip to main content
. 2021 Jan 27;10(3):241–250. doi: 10.1002/cpdd.909

Table 2.

Nicotine Pharmacokinetic Parameters

A. Cmax(0‐180) (ng/mL)
Mean ± SD Geo. LS Mean Geo. LS Mean Ratio (95%CI), Test/Cigarette (%) Geo. LS Mean Ratio (95%CI), Test/Gum (%)
Own‐brand cigarette (n = 26) 13.56 ± 7.1747 12.11
Nicotine polacrilex gum (n = 26) 2.781 ± 1.8058 2.04
Test 1 (n = 27) 2.894 ± 0.95257 2.73 22.57 (17.78‐28.65) a 133.72 (105.38‐169.69) b
Test 2 (n = 27) 3.133 ± 1.2021 2.90 23.99 (18.91‐30.45) a 142.14 (111.99‐180.40) b
B. AUC0‐180 (ng·min/mL)
Mean ± SD Geo. LS Mean Geo. LS Mean Ratio (95%CI), Test/Cigarette (%) Geo. LS Mean Ratio (95%CI), Test/Gum (%)
Own‐brand cigarette (n = 26) 1017 ± 303.53 946.29
Nicotine polacrilex gum (n = 26) 332.0 ± 205.17 246.30
Test 1 (n = 27) 349.1 ± 121.81 327.11 34.57 (28.12‐42.49) a 132.81 (108.07‐163.21) b
Test 2 (n = 27) 380.0 ± 155.44 348.98 36.88 (30.01‐45.32) a 141.69 (115.28‐174.15) b

Values are presented as arithmetic mean ± SD, geometric least‐squares mean and geometric least‐squares mean ratio (%) with sample size (n) and the 95% confidence interval (CI) for the geometric mean ratio between the test products and own‐brand cigarette and nicotine polacrilex gum.

a

P < .0001.

b

P < .05.